Sarana Meditama (Indonesia) Today
| SAME Stock | IDR 302.00 4.00 1.31% |
PerformanceModest
| Odds Of DistressBelow Average
|
Sarana Meditama is selling for 302.00 as of the 26th of March 2025. This is a 1.31% down since the beginning of the trading day. The stock's last reported lowest price was 298.0. Sarana Meditama has about a 34 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia. The company has 17.13 B outstanding shares. More on Sarana Meditama Metropolitan
Moving against Sarana Stock
Sarana Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sarana Meditama's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sarana Meditama or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Providers & Services, Medical Care, Healthcare (View all Sectors) |
Sarana Meditama Metropolitan (SAME) is traded on Jakarta Exchange in Indonesia and employs 2,437 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 5.31 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sarana Meditama's market, we take the total number of its shares issued and multiply it by Sarana Meditama's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sarana Meditama Metr operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 17.13 B outstanding shares.
Sarana Meditama Metropolitan has accumulated about 470 B in cash with 253.74 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.36.
Check Sarana Meditama Probability Of Bankruptcy
Ownership AllocationSarana Meditama Metr shows a total of 17.13 Billion outstanding shares. Sarana Meditama Metr has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.36 % of Sarana Meditama outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sarana Ownership Details
Sarana Meditama Metr Risk Profiles
Although Sarana Meditama's alpha and beta are two of the key measurements used to evaluate Sarana Meditama's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.6 | |||
| Semi Deviation | 2.63 | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.46 |
Sarana Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sarana Meditama without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Sarana Meditama Corporate Management
Elected by the shareholders, the Sarana Meditama's board of directors comprises two types of representatives: Sarana Meditama inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sarana. The board's role is to monitor Sarana Meditama's management team and ensure that shareholders' interests are well served. Sarana Meditama's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sarana Meditama's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Armen Djan | CFO Director | Profile | |
| Nailufar | Head Director | Profile | |
| Agnes Pricilia | Head Audit | Profile | |
| Jusup Halimi | CEO Director | Profile | |
| Meta MD | Medical Director | Profile | |
| Rahmiyati Yahya | Co Sec | Profile |
Other Information on Investing in Sarana Stock
Sarana Meditama financial ratios help investors to determine whether Sarana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarana with respect to the benefits of owning Sarana Meditama security.